RF POWER AMPLIFIER DESIGN TECHNIQUE FOR 5G WIRELESS COMMUNICATION SYSTEMS
ICTACT Journal on Microelectronics · 01.04.2024 · 10 (1) · 1711
DOI: 10.21917/ijme.2024.0296 ↗Kurz gefasst
Fachartikel in der Zeitschrift ICTACT Journal on Microelectronics, online erschienen am 01.04.2024. Verfasst von Menaka G und 3 weiteren Autor:innen.
Abstract (Originalsprache)
This study explores the design technique for an RF Power Amplifier (PA) using the Qorvo QPA4501 Power Amplifier Module (PAM) tailored for Massive Multiple Input Multiple Output (MIMO) systems, addressing the need for efficient and linear amplification in modern wireless communication networks. The design process involves thorough analysis of the QPA4501 datasheet, impedance matching, power control implementation, linearity optimization, thermal management considerations, system integration, and rigorous testing. This research contributes a comprehensive approach to designing RF PAs for Massive MIMO systems, leveraging the capabilities of the Qorvo QPA4501 PAM to achieve high performance and reliability. Simulation and testing demonstrate the effectiveness of the proposed design technique, showcasing improved power efficiency, linearity, and thermal stability, meeting the stringent requirements of Massive MIMO applications.
Zitieren
APA
G, M., Rappai, S., Pitty, N., & S, E. R. (2024). RF POWER AMPLIFIER DESIGN TECHNIQUE FOR 5G WIRELESS COMMUNICATION SYSTEMS. ICTACT Journal on Microelectronics, 10(1), 1711. https://doi.org/10.21917/ijme.2024.0296
Vancouver
G M, Rappai S, Pitty N, S ER. RF POWER AMPLIFIER DESIGN TECHNIQUE FOR 5G WIRELESS COMMUNICATION SYSTEMS. ICTACT Journal on Microelectronics. 2024;10(1):1711. doi:10.21917/ijme.2024.0296
BibTeX
@article{G2024,
author = {G, Menaka and Rappai, Sherin and Pitty, Nagarjuna and S, Esakki Rajavel},
title = {RF POWER AMPLIFIER DESIGN TECHNIQUE FOR 5G WIRELESS COMMUNICATION SYSTEMS},
journal = {ICTACT Journal on Microelectronics},
year = {2024},
volume = {10},
number = {1},
pages = {1711},
doi = {10.21917/ijme.2024.0296}
}
EUVIMED